title: How to protect hypertrophied myocardium? A prospective clinical trial of three preservation techniques.
abstract: Protection of the hypertrophied myocardium during heart surgery is still a controversial matter. We prospectively studied 3 currently available preservation techniques in 60 patients operated on for isolated aortic stenosis. Patients were randomly assigned to one of the following groups: CWB: continuous warm blood cardioplegia ICB: intermittent cold blood with warm blood controlled reperfusion Cryst: intermittent cold crystalloid cardioplegia (SLF11, Biosédra Laboratory, Vernon, France). All groups were matched for age, ejection fraction, NYHA class, aortic valve surface, and operative risk score. There were no deaths. No statistically significant difference was found among the groups in terms of ventilatory support time, ICU stay time, hospitalization or atrial fibrillation occurrence. Blood gases in the coronary sinus at the time of clamp release showed deep acidosis with crystalloid cardioplegia (pH = 7.11 vs 7.39 for CWB and 7.38 for UCB, p < 0.0001) associated with a higher lactate production than in the other groups (1.3 mmol vs 0.5 for CWB and 0.58 for ICB, p < 0.0001). Acidosis was corrected at the end of bypass with no significant differences among groups. CK-MB samples were taken on arrival in ICU, then 6 and 24 hours later. These samples showed much higher levels with cold blood (H6: 70 mcg/l vs 33 for CWB and 45 for Cryst, p = 0.0019). Although the 3 types of cardioplegia may be safely used for isolated aortic stenosis surgery, continuous warm blood cardioplegia appears to be the best choice.
authors.affiliation: Department of Thoracic and Cardiovascular Surgery, Hôpital Charles Nicolle, C.H.U., Rouen, France.
authors.forename: F
authors.initials: F
authors.lastname: Bouchart
authors.forename: J P
authors.initials: JP
authors.lastname: Bessou
authors.forename: A
authors.initials: A
authors.lastname: Tabley
authors.forename: B
authors.initials: B
authors.lastname: Hecketsweiller
authors.forename: D
authors.initials: D
authors.lastname: Mouton-Schleifer
authors.forename: M
authors.initials: M
authors.lastname: Redonnet
authors.forename: J
authors.initials: J
authors.lastname: Arrignon
authors.forename: R
authors.initials: R
authors.lastname: Soyer
mesh_terms: D000368:Aged; D001024:Aortic Valve Stenosis / Q000097:blood / Q000601:surgery; D006332:Cardiomegaly / Q000517:prevention & control*; D002314:Cardioplegic Solutions; D002315:Cardiopulmonary Bypass; D005260:Female; D006324:Heart Arrest, Induced / Q000379:methods*; D019918:Heart Valve Prosthesis Implantation; D006801:Humans; D008297:Male; D015425:Myocardial Reperfusion / Q000379:methods*; D009206:Myocardium / Q000378:metabolism; D011183:Postoperative Complications / Q000517:prevention & control*; D011446:Prospective Studies
chemical_list: D002314:Cardioplegic Solutions